Long-term effects of edaravone on survival of patients with amyotrophic lateral sclerosis

BACKGROUND AND PURPOSE: Oxidative stress has been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS). Edaravone, a free radical scavenger, was approved as a therapeutic drug for ALS in 2015 in Japan. A phase 3 clinical trial demonstrated a smaller decline in ALS functional scale s...

Descripción completa

Detalles Bibliográficos
Autores principales: Okada, Masamitsu, Yamashita, Satoshi, Ueyama, Hidetsugu, Ishizaki, Masatoshi, Maeda, Yasushi, Ando, Yukio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006910/
https://www.ncbi.nlm.nih.gov/pubmed/29928711
http://dx.doi.org/10.1016/j.ensci.2018.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006910/
https://www.ncbi.nlm.nih.gov/pubmed/29928711
http://dx.doi.org/10.1016/j.ensci.2018.05.001

Ejemplares similares